ÂÜÀòÂÒÂ×

Sunny Reddy is an experienced professional in the biotechnology and healthcare investment sectors, currently serving as a Board Observer at Mindful Health Solutions and multiple other firms including Garuda Therapeutics, Monte Rosa Therapeutics, Wugen, and Forge Biologics. As a Principal at Aisling Capital since September 2019, Sunny has contributed to strategic decision-making and investments. Previous roles include Associate at Leerink Partners LLC and Quantitative Analyst at Bank of America Merrill Lynch. Sunny holds an MBA from Columbia Business School and a Bachelor's Degree in Biomedical Engineering from Georgia Institute of Technology.